Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison Between Hybrid, Reverse Hybrid, and Non-Bismuth Levofloxacin Quadruple Regimens for Helicobacter Pylori Infection in Egypt: A Randomized Controlled Trial

NCT04039412 is registered in ClinicalTrials.gov with Ayman Magd Eldin Mohammad Sadek as lead sponsor.

NCT NCT04039412
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04039412 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison Between Hybrid, Reverse Hybrid, and Non-Bismuth Levofloxacin Quadruple Regimens for Helicobacter Pylori Infection in Egypt: A Randomized Controlled Trial
Lead sponsor
Ayman Magd Eldin Mohammad Sadek
Phase
Phase 4
Overall status
Completed
Start date
June 1, 2018
Completion date
June 30, 2019
Enrollment
330 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

helicobacter pylori infection